ArticleJIMD reports2025
Self-Reported Liver Disease and the Burden of Erythropoietic Protoporphyria.
Article in JIMD reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erythropoietic protoporphyria (EPP) and X-linked protoporphyria are metabolic disorders that cause skin phototoxicity and potential liver damage. We compared symptoms and impacts of phototoxic reactions, health-related quality of life, and healthcare utilization (HCU) between individuals with and without self-reported liver disease (elevated liver enzymes or liver fibrosis) using an online questionnaire containing validated patient-reported outcome measures and original items. Among 164 participants, 15.2% self-reported liver disease. Sixty-four percent of those with liver disease rated their general health "much worse" than those without EPP, versus 35% of those without liver disease. Those with liver disease had a higher frequency of prodromal symptoms and more frequently reported that their most recent phototoxic reaction impacted their ability to perform daily activities (76% versus 55% for those without liver disease) and resulted in difficulty in doing chores (88% versus 60%) or going for a walk, run, or bike ride (84% versus 60%). A higher percentage of those with liver disease reported feeling anxious (92% versus 78%), isolated (100% versus 80%), and lonely (96% versus 72%) than those without liver disease. The mean number of hours missed from work and school in the past month was higher for those with liver disease (work: 10.9 h; school: 7.7 h) than those without liver disease (3.6 h for both). EPP-related HCU in the previous 12 months was higher for those with liver disease than those without liver disease, including more physician visits (mean of 16.5 versus 6.0) and emergency room visits (mean of 9.0 versus 1.9).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.